Autoimmune complications of COVID‐19
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID‐19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID‐19 disease period, there is an accumulating body of evidence concerning the late‐onset complications of COVID‐19, of which autoimmune manifestations have attracted remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain‐Barre syndrome, and the detection of autoantibodies are the cues to the discovery of the potential of COVID‐19 in inducing autoimmunity. Clarification of the pathophysiology of COVID‐19 injuries to the host, whether it is direct viral injury or autoimmunity, could help to develop appropriate treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · cited 4×
“They reported a higher elevated level of IL‐2R, IL‐6, IL‐8, IL‐10, and TNF‐α in severe cases compared to non‐severe cases.(52) Moreover, although the total”
BackgroundResultInfluentialAutoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662 · cited 1×
“infection and considering the earlier experience of the delay between the surge in the number of MIS‐C or Kawasaki‐like disease and the spread peaks of COVID‐19, a time gap is expectable between the COVID‐19 pandemic and autoimmune presentations.(137) Hence, a more precise understanding of the involved mechanisms pote…”
BackgroundMultisystem Inflammatory Syndrome in U.S. Children and Adolescents
Feldstein, L. R., Rose, E. B., Horwitz, S. M., Collins, J. P., Newhams, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021680 · Cited by 2,643 · cited 2×
“Gastrointestinal, cardiovascular, hematologic, mucocutaneous, and respiratory involvement was of the most common findings in COVID‐19 pediatric patients presented with MIS‐C, respectively.(58) These findings are in line with the obtained results from the same studies.”
BackgroundResultHyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380 · cited 1×
“United States Cohort 186 Feldstein et al.(59)”
Whittaker, E., Bamford, A., Kenny, J., Kaforou, M., Jones, C. E., Shah, P., Ramnarayan, P., Fraisse, A., Miller, O., Davies, P., et al. (2020) · JAMA · doi:10.1001/jama.2020.10369 · Cited by 1,994
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · cited 1×
“of immune components that could result in autoimmune reactions.(63) MIS‐C demonstrates both type II and type IV hypersensitivity characteristics.”
BackgroundLippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706 · cited 1×
“analysis suggested that thrombocytopenia is more pronounced in patients with a severe form of COVID‐19 infection.(82) Similar to COVID‐19, SARS‐CoV has been reported to be associated with”
ResultMultisystem Inflammatory Syndrome in Children in New York State
Dufort, E. M., Koumans, E. H., Chow, E. J., Rosenthal, E. M., Muse, A., Rowlands, J., Barranco, M. A., Maxted, A. M., Rosenberg, E. S., Easton, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021756 · Cited by 1,350
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Toubiana, J., Poirault, C., Corsia, A., Bajolle, F., Fourgeaud, J., Angoulvant, F., Debray, A., Basmaci, R., Salvador, E., Biscardi, S., et al. (2020) · BMJ · doi:10.1136/bmj.m2094 · Cited by 1,144 · cited 1×
“France Case series 35 Belhadjer et al.(62)”
Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., Auriau, J., Grimaud, M., Oualha, M., Beghetti, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048360 · Cited by 1,129
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 993 · cited 2×
“system was a case of a patient who developed weakness of her lower limbs that progressed to upper limbs within three days.(68) This pa-”
BackgroundThe epidemiology of autoimmune diseases
Cooper, G. S., & Stroehla, B. C. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00006-5 · Cited by 880 · cited 1×
“individuals, and the healthcare system as well, as these are prevalent chronic conditions with no definite treatment up to date.(46,47) Taken together, the concomitance of COVID‐19 infection and autoimmune”
BackgroundMiller Fisher syndrome and polyneuritis cranialis in COVID-19
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Mañas, R., de Aragón-Gómez, F., & Benito-León, J. (2020) · Neurology · doi:10.1212/wnl.0000000000009619 · Cited by 810
Cooper, G. S., Bynum, M. L. K., & Somers, E. C. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.008 · Cited by 736 · cited 1×
“individuals, and the healthcare system as well, as these are prevalent chronic conditions with no definite treatment up to date.(46,47) Taken together, the concomitance of COVID‐19 infection and autoimmune”
BackgroundAntibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Lee, W. S., Wheatley, A. K., Kent, S. J., & DeKosky, B. J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00789-5 · Cited by 676 · cited 1×
“with immune complexes formed by IgG that potentially boosts viral replication in Fc‐receptor expressing cells.(50) The observation of ADE by anti‐spike protein antibody of severe acute respiratory syndrome coronavirus (SARS‐CoV) further supports the possible role of ADE in autoimmunity mediated by COVID‐19.”
BackgroundProthrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660 · cited 2×
“Moreover, anti‐Ro/SSA and autoantibody against type I IFN were reported detectable in COVID‐19 patients.(135,136) In”
BackgroundViruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
Smatti, M. K., Cyprian, F. S., Nasrallah, G. K., Al Thani, A. A., Almishal, R. O., & Yassine, H. M. (2019) · Viruses · doi:10.3390/v11080762 · Cited by 544
Pouletty, M., Borocco, C., Ouldali, N., Caseris, M., Basmaci, R., Lachaume, N., Bensaid, P., Pichard, S., Kouider, H., Morelle, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217960 · Cited by 542
Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoimmune Disease After Viral Infection
Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P. A., & Cantor, H. (1998) · Science · doi:10.1126/science.279.5355.1344 · Cited by 512 · cited 1×
“Production of autoantibodies following a viral infection that potentially leads to tissue injury (cross‐reaction) is the suggested mechanism for viral‐induced autoimmunity based on the concept of type II hypersensitivity.(49) Regarding type IV hypersensitivity, it is suggested that activated T cells against the virus…”
BackgroundHemophagocytic lymphohistiocytosis: review of etiologies and management
George, M. (2014) · Journal of Blood Medicine · doi:10.2147/jbm.s46255 · Cited by 488 · cited 1×
“The described immune dysregulation along with the overproduction of cytokines that potentially leads to self‐tissue damage is known as secondary hemophagocytic lymphohistiocytosis (HLH) that could usually appear following viral infections.(53,54) The secondary HLH is documented in SARS‐CoV patients as well.”
BackgroundDisease and healthcare burden of COVID-19 in the United States
Miller, I. F., Becker, A. D., Grenfell, B. T., & Metcalf, C. J. E. (2020) · Nature Medicine · doi:10.1038/s41591-020-0952-y · Cited by 460 · cited 1×
“physical health complications of social isolation, and healthcare expenses, the huge burden of this pandemic is evident.(45) On the other”
BackgroundThe role of infections in autoimmune disease
Ercolini, A. M., & Miller, S. D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03834.x · Cited by 413 · cited 1×
“Epitope spreading, bystander activation, cross‐reaction or molecular mimicry, and presentation of cryptic antigens are the suggested mechanisms.(13) For instance, type 1 diabetes mellitus (T1DM) as one of the most prevalent autoimmune diseases has been suggested to be associated with coxsackievirus,(14) cytomegaloviru…”
BackgroundAutoimmune and inflammatory diseases following COVID-19
Galeotti, C., & Bayry, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0448-7 · Cited by 402
Ramcharan, T., Nolan, O., Lai, C. Y., Prabhu, N., Krishnamurthy, R., Richter, A. G., Jyothish, D., Kanthimathinathan, H. K., Welch, S. B., Hackett, S., et al. (2020) · Pediatric Cardiology · doi:10.1007/s00246-020-02391-2 · Cited by 364
Lin, Y. L., & Askonas, B. A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.2.225 · Cited by 342
Guillain-Barré syndrome related to COVID-19 infection
Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M. L., Santoro, P., Viganò, M., Giovannelli, G., Pirro, F., Montisano, D. A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000741 · Cited by 335
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., et al. (2021) · Brain · doi:10.1093/brain/awaa433 · Cited by 333
ASSOCIATION OF CYTOMEGALOVIRUS INFECTION WITH AUTOIMMUNE TYPE 1 DIABETES
Pak, C., Mcarthur, R., Eun, H.-M., & Yoon, J.-W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92941-8 · Cited by 321 · cited 1×
“CMV Pak et al.(15) Enteroviruses Stene and Rewers(16)”
BackgroundImmune Thrombocytopenic Purpura in a Patient with Covid-19
Zulfiqar, A.-A., Lorenzo-Villalba, N., Hassler, P., & Andrès, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010472 · Cited by 319
Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study
Chen, M., Zhou, W., & Xu, W. (2021) · Thyroid · doi:10.1089/thy.2020.0363 · Cited by 315
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
Autoimmune haemolytic anaemia associated with COVID‐19 infection
Lazarian, G., Quinquenel, A., Bellal, M., Siavellis, J., Jacquy, C., Re, D., Merabet, F., Mekinian, A., Braun, T., Damaj, G., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16794 · Cited by 300 · cited 1×
“France Case series 7 Lazarian et al.(120)”
Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines
Filipovich, A., McClain, K., & Grom, A. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.11.014 · Cited by 294 · cited 1×
“The described immune dysregulation along with the overproduction of cytokines that potentially leads to self‐tissue damage is known as secondary hemophagocytic lymphohistiocytosis (HLH) that could usually appear following viral infections.(53,54) The secondary HLH is documented in SARS‐CoV patients as well.”
BackgroundDesforges, M., Le Coupanec, A., Brison, É., Meessen-Pinard, M., & Talbot, P. J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-81-322-1777-0_6 · Cited by 281 · cited 1×
“Existing reports on the neurologic autoimmune manifestations following infection with other coronaviruses such as SARS‐CoV and Middle East respiratory syndrome coronavirus, further support the notion that COVID‐19 might be capable of inducing autoimmune reactions against the nervous system.(75,76)”
BackgroundHuman coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis
Desforges, M., Le Coupanec, A., Stodola, J. K., Meessen-Pinard, M., & Talbot, P. J. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.011 · Cited by 275 · cited 1×
“Existing reports on the neurologic autoimmune manifestations following infection with other coronaviruses such as SARS‐CoV and Middle East respiratory syndrome coronavirus, further support the notion that COVID‐19 might be capable of inducing autoimmune reactions against the nervous system.(75,76)”
BackgroundA cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?
Holmes, G. P. (1987) · JAMA · doi:10.1001/jama.257.17.2297 · Cited by 254
Viral infections associated with Kawasaki disease
Chang, L.-Y., Lu, C.-Y., Shao, P.-L., Lee, P.-I., Lin, M.-T., Fan, T.-Y., Cheng, A.-L., Lee, W.-L., Hu, J.-J., Yeh, S.-J., et al. (2014) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.12.008 · Cited by 236
Mateu-Salat, M., Urgell, E., & Chico, A. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01366-7 · Cited by 213
Vlachoyiannopoulos, P. G., Magira, E., Alexopoulos, H., Jahaj, E., Theophilopoulou, K., Kotanidou, A., & Tzioufas, A. G. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218009 · Cited by 205 · cited 1×
“For instance, antinuclear antibodies (ANA), lupus anticoagulant, anti‐β2glycoprotein 1, and an anticardiolipin antibody that could be the cause of thromboembolic events in COVID‐19 patients.(11,134,135) Moreover, anti‐Ro/SSA and autoantibody against type I IFN were reported detectable in COVID‐19 patients.”
BackgroundFrequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients
Ablashi, D. V., Eastman, H. B., Owen, C. B., Roman, M. M., Friedman, J., Zabriskie, J. B., Peterson, D. L., Pearson, G. R., & Whitman, J. E. (2000) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)00079-7 · Cited by 197
Filosto, M., Cotti Piccinelli, S., Gazzina, S., Foresti, C., Frigeni, B., Servalli, M. C., Sessa, M., Cosentino, G., Marchioni, E., Ravaglia, S., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324837 · Cited by 197
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
Guilmot, A., Maldonado Slootjes, S., Sellimi, A., Bronchain, M., Hanseeuw, B., Belkhir, L., Yombi, J. C., De Greef, J., Pothen, L., Yildiz, H., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10108-x · Cited by 190
Thrombocytopenia in patients with severe acute respiratory syndrome (review)
Yang, M., Ng, M. H., & Li, C. K. (2005) · Hematology · doi:10.1080/10245330400026170 · Cited by 185
Neurologic manifestations associated with COVID-19: a multicentre registry
Meppiel, E., Peiffer‐Smadja, N., Maury, A., Bekri, I., Delorme, C., Desestret, V., Gorza, L., Hautecloque-Raysz, G., Landre, S., Lannuzel, A., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.11.005 · Cited by 176
Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience
Riollano‐Cruz, M., Akkoyun, E., Briceno‐Brito, E., Kowalsky, S., Reed, J., Posada, R., Sordillo, E. M., Tosi, M., Trachtman, R., & Paniz‐Mondolfi, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26224 · Cited by 170
Zivadinov, R., Guan, Y., Jakimovski, D., Ramanathan, M. K., & Weinstock‐Guttman, B. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.245462 · Cited by 167
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Mohamed, K., Yazdanpanah, N., Saghazadeh, A., & Rezaei, N. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104490 · Cited by 166
Self-citationSaghazadeh, A., & Rezaei, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106560 · Cited by 162 · cited 1×
“process of designing the treatment strategy, if translated to clinical utilization.(12)”
MethodSelf-citationCOVID‐19‐associated immune thrombocytopenia
Bomhof, G., Mutsaers, P. G. N. J., Leebeek, F. W. G., te Boekhorst, P. A. W., Hofland, J., Croles, F. N., & Jansen, A. J. G. (2020) · British Journal of Haematology · doi:10.1111/bjh.16850 · Cited by 161 · cited 1×
“The Netherlands Case series 3 Bomhof et al.(109)”
BackgroundEsposito, S., & Longo, M. R. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.022 · Cited by 150
Incidence, clinical, risk factors and outcomes of Guillain‐Barré in Covid‐19
Fragiel, M., Miró, Ò., Llorens, P., Jiménez, S., Piñera, P., Burillo, G., Martín, A., Martín‐Sánchez, F. J., García‐Lamberechts, E. J., Jacob, J., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25987 · Cited by 130
SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences
Lotfi, M., & Rezaei, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26123 · Cited by 128
Self-citationStene, L. C., & Rewers, M. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04555.x · Cited by 118 · cited 1×
“For instance, type 1 diabetes mellitus (T1DM) as one of the most prevalent autoimmune diseases has been suggested to be associated with coxsackievirus,(14) cytomegalovirus (CMV),(15) and enteroviruses.(16) Different types of viral infections such as hepatitis C virus (HCV),(17) CMV,(18) dengue virus,(19) and parvoviru…”
BackgroundEspíndola, O. D. M., Brandão, C. O., Gomes, Y. C. P., Siqueira, M. M., Soares, C., Lima, M. A., Leite, A. C. C. B., Torezani, G. S., Araújo, A., & Silva, M. T. T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.044 · Cited by 116
Gazzaruso, C., Carlo-Stella, N., Mariani, G., Nai, C., Coppola, A., Naldani, D., & Gallotti, P. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05180-7 · Cited by 116 · cited 1×
“For instance, antinuclear antibodies (ANA), lupus anticoagulant, anti‐β2glycoprotein 1, and an anticardiolipin antibody that could be the cause of thromboembolic events in COVID‐19 patients.(11,134,135) Moreover, anti‐Ro/SSA and autoantibody against type I IFN were reported detectable in COVID‐19 patients.”
BackgroundSimultaneous onset of COVID‐19 and autoimmune haemolytic anaemia
Lopez, C., Kim, J., Pandey, A., Huang, T., & DeLoughery, T. G. (2020) · British Journal of Haematology · doi:10.1111/bjh.16786 · Cited by 112
Rational Vaccine Design in the Time of COVID-19
Burton, D. R., & Walker, L. M. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.022 · Cited by 106
Viral-Associated Immune Thrombocytopenic Purpura
Liebman, H. A. (2008) · Hematology · doi:10.1182/asheducation-2008.1.212 · Cited by 105 · cited 1×
“It has been reported in association with viral infections such as human immunodeficiency virus and HCV that are the well‐described ones.(77) Thrombocytopenia in a moderate form is reported in about 36% of admitted COVID‐19 patients.”
BackgroundPaybast, S., Gorji, R., & Mavandadi, S. (2020) · The Neurologist · doi:10.1097/nrl.0000000000000291 · Cited by 103
Guillain-Barré syndrome related to SARS-CoV-2 infection
Bigaut, K., Mallaret, M., Baloglu, S., Némoz, B., Morand, P., Baicry, F., Godon, A., Voulleminot, P., Kremer, L. D., Chanson, J., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000785 · Cited by 103
Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review.
Cascio, A., Pernice, L. M., Barberi, G., Delfino, D., Biondo, C., Beninati, C., Mancuso, G., Rodriguez-Morales, A. J., & Iaria, C. (2012) · PubMed · Cited by 101
Miller‐Fisher syndrome after SARS‐CoV‐2 infection
Bueno, J. A. R., Trujillo, L. G., Urbaneja, P., Ciano-Petersen, N. L., Postigo-Pozo, M. J., Martínez‐Tomás, C., & Serrano-Castro, P. J. (2020) · European Journal of Neurology · doi:10.1111/ene.14383 · Cited by 98
Mahévas, M., Moulis, G., Andrès, E., Rivière, É., Garzaro, M., Crickx, É., Guillotin, V., Malphettes, M., Galicier, L., Noël, N., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17024 · Cited by 97 · cited 1×
“France Case series 14 Mahévas et al.(112)”
Fujii, H., Tsuji, T., Yuba, T., Tanaka, S., Suga, Y., Matsuyama, A., Omura, A., Shiotsu, S., Takumi, C., Ono, S., et al. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05359-y · Cited by 85 · cited 1×
“Moreover, anti‐Ro/SSA and autoantibody against type I IFN were reported detectable in COVID‐19 patients.(135,136) In”
BackgroundManganotti, P., Bellavita, G., D’Acunto, L., Tommasini, V., Fabris, M., Sartori, A., Bonzi, L., Stella, A. B., & Pesavento, V. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26289 · Cited by 85 · cited 1×
“Italy Case series 5 Manganotti et al.(103)”
Rial, J. G., Calle, I. R., Salas, A., & Martinón‐Torres, F. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.041 · Cited by 80
Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
Anaya, J., Monsalve, D. M., Rojas, M., Rodríguez, Y., Montoya-García, N., Mancera-Navarro, L. M., Villadiego-Santana, A. M., Rodríguez-Leguizamón, G., Acosta‐Ampudia, Y., & Ramı́rez-Santana, C. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100091 · Cited by 79
SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome
Lascano, A. M., Epiney, J., Coen, M., Serratrice, J., Bernard‐Valnet, R., Lalive, P. H., Küntzer, T., & Hübers, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14368 · Cited by 72 · cited 1×
“Switzerland Case series 3 Lascano et al.(102)”
Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
Vanheusden, M., Broux, B., Welten, S. P. M., Peeters, L. M., Panagioti, E., Wijmeersch, B. V., Somers, V. A., Stinissen, P., Arens, R., & Hellings, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-00645-3 · Cited by 68 · cited 1×
“CMV Thakolwiboon et al.(25,26) Theiler's virus Miller et al.”
BackgroundInsights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors
Lui, D. T. W., Lee, C., Chow, W. S., Lee, A. C. H., Tam, A. R., Fong, C. H. Y., Law, C. Y., Leung, E. K. H., To, K. K., Tan, K. C. B., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.983 · Cited by 66
COVID-19 infection associated with autoimmune hemolytic anemia
Capes, A., Bailly, S., Hantson, P. E., Gérard, L., & Laterre, P. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04137-9 · Cited by 64
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
Albiol, N., Awol, R., & Martino, R. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04097-0 · Cited by 64
Miller, S. D., Katz‐Levy, Y., Neville, K. L., & Vanderlugt, C. L. (2001) · Advances in virus research · doi:10.1016/s0065-3527(01)56008-x · Cited by 63
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
Hindilerden, F., Hindilerden, İ. Y., Akar, E., & Yaşar, K. K. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.07.005 · Cited by 57
COVID-19: Infection or Autoimmunity
Icenogle, T. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02055 · Cited by 54 · cited 1×
“MIS‐C demonstrates both type II and type IV hypersensitivity characteristics.(64) The delay between the emergence of autoinflammatory syndromes and COVID‐19 spread peaks might strengthen the possibility of virus‐induced immune‐mediated mechanisms underlying the reported clinical manifestations.”
BackgroundSevere autoimmune hemolytic anemia in Covid-19 infection
Hindilerden, F., Hindilerden, İ. Y., Akar, E., Yeşilbağ, Z., & Yaşar, K. K. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.053 · Cited by 48
Miller Fisher syndrome and COVID-19: is there a link?
Ray, A. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236419 · Cited by 42
Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review
Ahmed, M. Z., Khakwani, M. Z., Venkatadasari, I., Horgan, C., Giles, H. V., Jobanputra, S., Lokare, A., Ewing, J. C., Paneesha, S., & Murthy, V. (2020) · British Journal of Haematology · doi:10.1111/bjh.16769 · Cited by 39 · cited 1×
“Immune thrombocytopenic purpura UK Case series 3 Ahmed et al.(108)”
BackgroundCoronavirus disease associated immune thrombocytopenia: Causation or correlation?
Pascolini, S., Granito, A., Muratori, L., Lenzi, M., & Muratori, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.08.006 · Cited by 35 · cited 1×
“Italy Case series 3 Pascolini et al.(113)”
Garnero, M., Sette, M. D., Assini, A., Beronio, A., Capello, E., Cabona, C., Reni, L., Serrati, C., Bandini, F., Granata, A., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117114 · Cited by 34
Guillain-Barré Syndrome Associated With COVID-19
Ebrahimzadeh, S. A., Ghoreishi, A., & Rahimian, N. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000879 · Cited by 32 · cited 1×
“Iran Case series 2 Ebrahimzadeh et al.(92)”
Autoimmune hepatitis following Epstein–Barr virus infection
Cabibi, D. (2025) · BMJ Case Reports · doi:10.1136/bcr.06.2008.0071 · Cited by 30
Wj, M. (2008) · Pathobiology · doi:10.1159/000164104 · Cited by 28
Thakolwiboon, S., Zhao-Fleming, H. H., Karukote, A., Pachariyanon, P., Williams, H. G., & Avila, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102393 · Cited by 26 · cited 1×
“CMV Thakolwiboon et al.(25,26) Theiler's virus Miller et al.”
BackgroundKawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19
Sarzaeim, M., & Rezaei, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00558-9 · Cited by 25
Self-citationHasan, M. R., Zubaidi, K. A., Diab, K. A., Hejazi, Y., Bout‐Tabaku, S., Al‐Adba, B., Maslamani, E. A., Janahi, M. A., Roscoe, D. L., Lopez, A. P., et al. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02743-8 · Cited by 25
Chan, A., ROSE, J. W., Álvarez, E., Bar‐Or, A., Butzkueven, H., Fox, R. J., Gold, R., Gudesblatt, M., Haartsen, J., Spelman, T. D., et al. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000800 · Cited by 25
Guillain-Barre Syndrome and COVID-19: A case report
Bueso, T., Montalván, V., Lee, J., et al. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106413 · Cited by 24
Enterovirus in the Chronic Fatigue Syndrome
McGarry, F., Gow, J., & Behan, P. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00020 · Cited by 21
Thrombocytopenia in the Course of COVID-19 Infection
Lorenzo-Villalba, N., Zulfiqar, A., Auburtin, M., Schuhmacher, M. H., Meyer, A., Maouche, Y., Keller, O., & Andrès, E. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001702 · Cited by 21 · cited 1×
“France Case series 3 Lorenzo‐Villalba et al.(111)”
West Nile Virus infection with hearing loss
McBride, W. M. D., Gill, K. R., & Wiviott, L. D. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.017 · Cited by 18
de Langavant, L. C., Petit, A., Nguyen, Q. T. R., Gendre, T., Abdelhedi, J., Djellaoui, A., Seddik, L., Lim, L., Faugeras, F., Salhi, H. S., et al. (2021) · Revue Neurologique · doi:10.1016/j.neurol.2021.01.004 · Cited by 18 · cited 1×
“France Case series 2 Cleret de Langavant et al.(101)”
BackgroundCoxsackievirus and Type 1 Diabetes Mellitus: The Wolf’s Footprints
Eizirik, D. L., & Beeck, A. O. D. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.12.002 · Cited by 17
Kurz, H., & Gombala, T. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.656768 · Cited by 17
Cytomegalovirus as a Driver of Excess Cardiovascular Mortality in Rheumatoid Arthritis
Pera, A., Broadley, I., Davies, K. A., & Kern, F. (2017) · Circulation Research · doi:10.1161/circresaha.116.309982 · Cited by 17
Neurological Manifestations of COVID-19: A Series of Seven Cases
Goel, K., Diwan, S., Kohli, S., Sachdeva, H. C., & Mustafi, S. M. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23723 · Cited by 12
Guillain-Barré Syndrome in a COVID-19 Patient: A Case Report and Review of Management Strategies
Mostel, Z., Ayat, P., Capric, V., Trimmingham, A., & McFarlane, S. I. (2021) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-9-3-16 · Cited by 10
Ionescu, M. D., Taraş, R., Dombici, B., Bălgrădean, M., Berghea, C. E., & Nicolescu, A. M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040318 · Cited by 8
Metadata
- Authors
- Yazdanpanah, N., & Rezaei, N.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2021-08-31
- Volume
- 94
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3196174775
- Cited by
- 165
- References
- 104
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.